According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -โน4.53 B. In 2023 the company made an earning of -โน3.46 B an increase over its 2022 earnings that were of -โน9.12 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.